• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BioInvent International AB

+ Add to Watchlist


3.2000 SEK 0.0500 1.54%

As of 11:29:59 ET on 09/17/2014.

Snapshot for BioInvent International AB (BINV)

Open: 3.2900 Day's Range: 3.1600 - 3.3100 Volume: 970,451
Previous Close: 3.2500 52wk Range: 2.1938 - 4.6418 1-Yr Rtn: +39.29%

Stock Chart for BINV

No chart data available.
  • BINV:SS 3.2000
  • 1D
  • 1M
  • 1Y
Interactive BINV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BINV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -0.1329
Est. EPS (SEK) (12/2014) -0.2270
Est. PEG Ratio -
Market Cap (M SEK) 360.93
Shares Outstanding (M) 112.79
30 Day Average Volume 277,051
Price/Book (mrq) 3.9592
Price/Sale (ttm) 3.1481
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BINV

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for BINV

BioInvent International AB is a research and development company within biotechnology. The Company has created human antibody libraries that can be used in a broad range of applications. BioInvent delivers proteins to drug and biotechnology companies, grants licenses for use of its libraries, and establishes partnerships to develop and manufacture protein based drugs.

Michael S OredssonPresident/CEOPer-Anders JohanssonSenior VP:Tech Operations
Martin WilesSenior VP:Business DevelopmentBjoern FrendeusVP:Preclinical Research
More Company Profile & Key Executives for BINV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil